Data analyzed were from 50,484 individuals. 
Of these individuals, 60% received the Moderna vaccine; 73% were female; ages ranged from 18 to 95 years old; 8% had prior COVID-19 diagnosis or positive test. 
A total of 2% had Epinephrine Autoinjector Prescription; 28% had any history of allergy documented; and 34% received their vaccine from 6:00 to 10:59, 44% from 11:00 to 15:59 and 22% from 16:00 to 21:59. 
